These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19148789)

  • 1. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.
    Bjarnason I; Takeuchi K
    J Gastroenterol; 2009; 44 Suppl 19():23-9. PubMed ID: 19148789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: a practical approach to the clinical management of NSAID enteropathy.
    Srinivasan A; De Cruz P
    Scand J Gastroenterol; 2017 Sep; 52(9):941-947. PubMed ID: 28587496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
    Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
    J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.
    Maiden L
    J Gastroenterol; 2009; 44 Suppl 19():64-71. PubMed ID: 19148796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAID-induced small intestinal damage--roles of various pathogenic factors.
    Takeuchi K; Satoh H
    Digestion; 2015; 91(3):218-32. PubMed ID: 25791157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and prevention of NSAID-induced enteropathy.
    Davies NM; Saleh JY; Skjodt NM
    J Pharm Pharm Sci; 2000; 3(1):137-55. PubMed ID: 10954683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of anti-rheumatic drugs on gut permeability and on the gut associated lymphoid tissue.
    Bjarnason I; Peters TJ
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):165-76. PubMed ID: 8674146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.
    Somasundaram S; Sigthorsson G; Simpson RJ; Watts J; Jacob M; Tavares IA; Rafi S; Roseth A; Foster R; Price AB; Wrigglesworth JM; Bjarnason I
    Aliment Pharmacol Ther; 2000 May; 14(5):639-50. PubMed ID: 10792129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAID enteropathy: could probiotics prevent it?
    Montalto M; Gallo A; Gasbarrini A; Landolfi R
    J Gastroenterol; 2013 Jun; 48(6):689-97. PubMed ID: 22875474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects of non-steroidal anti-inflammatory drugs in the lower gastrointestinal tract].
    Angi A; Lakatos L
    Orv Hetil; 2009 Jan; 150(1):27-34. PubMed ID: 19091672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
    Adebayo D; Bjarnason I
    Postgrad Med J; 2006 Mar; 82(965):186-91. PubMed ID: 16517800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
    Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies.
    Wallace JL
    Br J Pharmacol; 2012 Jan; 165(1):67-74. PubMed ID: 21627632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
    Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
    Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAID enteropathy and bacteria: a complicated relationship.
    Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
    J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
    Said H; Akiba Y; Narimatsu K; Maruta K; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
    Dig Dis Sci; 2017 Aug; 62(8):1944-1952. PubMed ID: 28523577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.
    Bjarnason I; Hayllar J; MacPherson AJ; Russell AS
    Gastroenterology; 1993 Jun; 104(6):1832-47. PubMed ID: 8500743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal antiinflammatory drugs and the small intestine.
    Fortun PJ; Hawkey CJ
    Curr Opin Gastroenterol; 2005 Mar; 21(2):169-75. PubMed ID: 15711208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(12):133-139. PubMed ID: 28635889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.
    Wallace JL
    World J Gastroenterol; 2013 Mar; 19(12):1861-76. PubMed ID: 23569332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.